New Dengue Vaccine May Up Infection In Low Affected Areas: Study
The newly licensed dengue vaccine may actually increase the incidence of infections if used in low transmission areas, a team of international researchers has warned. Dengue — a viral infection that records nearly 400 million cases per year — is spread by mosquitoes, and causes fever, headache, muscle and joint pain. The virus typically causes a mild first infection but a far worse one if someone is infected with the disease a second time, researchers said. The study found that the dengue vaccine with the trade name Dengvaxia can reduce…
Read More